Principal Financial Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-459
| Closed | -$15K | – | 2481 |
|
|
2024
Q1 | $15K | Sell |
459
-42
| -8% | -$1.37K | ﹤0.01% | 2416 |
|
|
2023
Q4 | $13.4K | Sell |
501
-36
| -7% | -$963 | ﹤0.01% | 2401 |
|
|
2023
Q3 | $32.5K | Buy |
537
+40
| +8% | +$2.42K | ﹤0.01% | 2378 |
|
|
2023
Q2 | $50.7K | Sell |
497
-7,305
| -94% | -$745K | ﹤0.01% | 2359 |
|
|
2023
Q1 | $1.38M | Sell |
7,802
-105
| -1% | -$18.6K | ﹤0.01% | 1813 |
|
|
2022
Q4 | $3.06M | Sell |
7,907
-268
| -3% | -$104K | ﹤0.01% | 1684 |
|
|
2022
Q3 | $2.75M | Sell |
8,175
-31
| -0.4% | -$10.4K | ﹤0.01% | 1658 |
|
|
2022
Q2 | $2.7M | Sell |
8,206
-1,960
| -19% | -$644K | ﹤0.01% | 1739 |
|
|
2022
Q1 | $4.45M | Sell |
10,166
-1,323
| -12% | -$579K | ﹤0.01% | 1699 |
|
|
2021
Q4 | $5.04M | Buy |
11,489
+1,682
| +17% | +$738K | ﹤0.01% | 1663 |
|
|
2021
Q3 | $5.45M | Sell |
9,807
-358
| -4% | -$199K | ﹤0.01% | 1659 |
|
|
2021
Q2 | $5.22M | Buy |
10,165
+9,876
| +3,417% | +$5.07M | ﹤0.01% | 1701 |
|
|
2021
Q1 | $226K | Sell |
289
-1
| -0.3% | -$782 | ﹤0.01% | 2347 |
|
|
2020
Q4 | $158K | Buy |
+290
| New | +$158K | ﹤0.01% | 2326 |
|